Response to: ' "Evaluation of the impact of concomitant fibromyalgia on TNF alpha blockers' effectiveness in axial spondyloarthritis: results of a prospective, multicentre study" by Moltó et al: still a long way to go in the assessment of patients with spondyloarthritis and concomitant fibromyalgia?' by Altobelli et al

Anna Moltó^{1

2}, Maxime Dougados^{1

2}

Affiliations

¹ Rheumatology Department, Cochin Hospital, AP-HP, Paris Descartes University, Paris, France.
² Clinical Epidemiology and Biostatistics, INSERM (U1153), PRES Sorbonne Paris-Cité, Paris, France.

Comment

Anna Moltó et al. Ann Rheum Dis. 2019 May.

. 2019 May;78(5):e40.

doi: 10.1136/annrheumdis-2018-213419. Epub 2018 Apr 3.

Anna Moltó^{1

2}, Maxime Dougados^{1

2}

¹ Rheumatology Department, Cochin Hospital, AP-HP, Paris Descartes University, Paris, France.
² Clinical Epidemiology and Biostatistics, INSERM (U1153), PRES Sorbonne Paris-Cité, Paris, France.

No abstract available

Keywords: anti-tnf; fibromyalgis/pain syndromes; spondyloarthritis.

Conflict of interest statement

Competing interests: None declared.

Evaluation of the impact of concomitant fibromyalgia on TNF alpha blockers' effectiveness in axial spondyloarthritis: results of a prospective, multicentre study.
Moltó A, Etcheto A, Gossec L, Boudersa N, Claudepierre P, Roux N, Lemeunier L, Martin A, Sparsa L, Coquerelle P, Soubrier M, Perrot S, Dougados M. Moltó A, et al. Ann Rheum Dis. 2018 Apr;77(4):533-540. doi: 10.1136/annrheumdis-2017-212378. Epub 2017 Nov 28. Ann Rheum Dis. 2018. PMID: 29183878
'Evaluation of the impact of concomitant fibromyalgia on TNF alpha blockers' effectiveness in axial spondyloarthritis: results of a prospective, multicentre study' by Moltó et al: still a long way to go in the assessment of patients with spondyloarthritis and concomitant fibromyalgia?
Altobelli A, Scrivo R, Valesini G. Altobelli A, et al. Ann Rheum Dis. 2019 May;78(5):e39. doi: 10.1136/annrheumdis-2018-213319. Epub 2018 Mar 23. Ann Rheum Dis. 2019. PMID: 29572290 No abstract available.